Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial Article

ESI Most Cited Paper International Collaboration

cited authors

  • Butts, Charles; Socinski, Mark A.; Mitchell, Paul L.; Thatcher, Nick; Havel, Libor; Krzakowski, Maciej; Nawrocki, Sergiusz; Ciuleanu, Tudor-Eliade; Bosquee, Lionel; Manuel Trigo, Jose; Spira, Alexander; Tremblay, Lise; Nyman, Jan; Ramlau, Rodryg; Wickart-Johansson, Gun; Ellis, Peter; Gladkov, Oleg; Pereira, Jose Rodrigues; Eberhardt, Wilfried Ernst Erich; Helwig, Christoph; Schroeder, Andreas; Shepherd, Frances A.; START Trial Team

authors

Publication Date

  • January 1, 2014

webpage

published in

category

start page

  • 59

end page

  • 68

volume

  • 15

issue

  • 1